Eris Lifesciences Ltd

ERIS

Company Profile

  • Business description

    Eris Lifesciences Ltd is an India-based company engaged in the manufacturing and sale of branded pharmaceutical formulations. It focuses on Lifestyle therapies such as Diabetes Care, Cardiac Care, Nutrition, Central Nervous System, and others. The company operates in a single segment that is pharmaceuticals. Some of its brands include LNBloc, Olmin, Eritel, Atorsave and Crevast. Geographically, the company generates key revenue from India followed by International markets operations spanning in Latin America, Africa, Asia-Pacific, the Middle East, and CIS regions.

  • Contact

    Ramdas Road
    Plot No. 142/2, Shivarth Ambit
    Off SBR, Near Swati Bungalows
    Bodakdev
    AhmedabadGJ380054
    IND

    T: +91 7969661000

    https://www.eris.co.in

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 March 2027

    Employees

    3,076

Stocks News & Analysis

stocks

An undervalued stock to buy that even Warren Buffett likes

Trading at an 18% discount, this wide-moat stock is a rare find.
stocks

ASX REIT downgraded following underwhelming exit

Discounted exit raises investor concerns.
stocks

Ahead of an IPO, the maths behind Databrick’s $190 billion valuation doesn’t add up

The data and AI company is one of the world’s strongest private companies, but a PitchBook report says it’s unattractive at the current price.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,850.705.100.06%
CAC 408,078.480.680.01%
DAX 4025,407.111.53-0.01%
Dow JONES (US)51,457.79370.83-0.72%
FTSE 10010,684.8810.37-0.10%
HKSE24,642.51132.420.54%
NASDAQ26,817.49251.23-0.93%
Nikkei 22565,877.62486.59-0.73%
NZX 50 Index13,830.6819.570.14%
S&P 5007,682.0661.35-0.79%
S&P/ASX 2008,679.7014.700.17%
SSE Composite Index3,823.6264.75-1.67%

Market Movers